These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33957271)

  • 1. Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.
    Goodoory VC; Houghton LA; Yiannakou Y; Black CJ; Ford AC
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):569-577.e3. PubMed ID: 33957271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study.
    Barberio B; Yiannakou Y; Houghton LA; Black CJ; Savarino EV; Ford AC
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e89-e101. PubMed ID: 33839276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
    Black CJ; Yiannakou Y; Houghton LA; Ford AC
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome.
    Barberio B; Houghton LA; Yiannakou Y; Savarino EV; Black CJ; Ford AC
    Am J Gastroenterol; 2021 Feb; 116(2):362-371. PubMed ID: 33009062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.
    Goodoory VC; Craig OF; Gracie DJ; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 Jun; 34(6):e14282. PubMed ID: 34612560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
    Goodoory VC; Houghton LA; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14268. PubMed ID: 34532930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
    Barberio B; Fairbrass KM; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2024 Feb; 36(2):e14713. PubMed ID: 37994228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of the Rome III and Rome IV criteria for diagnosis of irritable bowel syndrome in Indian and Bangladeshi communities and internal shifts in the diagnostic categories of bowel disorders of gut-brain interactions.
    Ghoshal UC; Rahman MM; Pratap N; Misra A; Sarker SA; Hasan M; Bangdiwala SI; Palsson OS; Sperber AD
    Neurogastroenterol Motil; 2023 Jun; 35(6):e14579. PubMed ID: 37010834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome.
    Goodoory VC; Mikocka-Walus A; Yiannakou Y; Houghton LA; Black CJ; Ford AC
    Am J Gastroenterol; 2021 Jul; 116(7):1485-1494. PubMed ID: 33840729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.
    Goodoory VC; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2023 May; 57(10):1083-1092. PubMed ID: 36914979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
    Fairbrass KM; Selinger CP; Gracie DJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
    Edwards T; Friesen C; Schurman JV
    BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Rome IV criteria on the prevalence of post-infection irritable bowel syndrome.
    Breen-Lyles M; Decuir M; Byale A; Smith K; Grover M
    Neurogastroenterol Motil; 2023 May; 35(5):e14532. PubMed ID: 36633303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
    Black CJ; Houghton LA; Ford AC
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and impact of self-reported irritable bowel symptoms in the general population.
    Van den Houte K; Carbone F; Pannemans J; Corsetti M; Fischler B; Piessevaux H; Tack J
    United European Gastroenterol J; 2019 Mar; 7(2):307-315. PubMed ID: 31080615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Aziz I; Törnblom H; Palsson OS; Whitehead WE; Simrén M
    Am J Gastroenterol; 2018 Jul; 113(7):1017-1025. PubMed ID: 29880963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
    Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Black CJ; Craig O; Gracie DJ; Ford AC
    Gut; 2021 Jun; 70(6):1110-1116. PubMed ID: 32973070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.